Equities

Beijing Tong Ren Tang Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Beijing Tong Ren Tang Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)30.60
  • Today's Change-0.10 / -0.33%
  • Shares traded4.86m
  • 1 Year change-18.31%
  • Beta1.1262
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sale of traditional Chinese patent medicines. The Company’s main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The Company distributes its products under the brand of Tongrentang. The Company is also involved in the operation of Tongrentang drug stores. The Company distributes its products in domestic market and to overseas markets.

  • Revenue in CNY (TTM)18.09bn
  • Net income in CNY1.35bn
  • Incorporated1997
  • Employees17.88k
  • Location
    Beijing Tong Ren Tang Co LtdNo. 52 Dongxinglong StreetDongcheng DistrictBEIJING 100062ChinaCHN
  • Phone+86 1 067179780
  • Fax+86 1 067152230
  • Websitehttps://gf.tongrentang.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Junshi Biosciences Co Ltd2.48bn-949.86m31.19bn2.67k--5.66--12.56-0.96-0.962.516.050.22030.84365.48963,148.80-9.45-17.61-12.31-22.0081.5968.46-42.92-84.561.43-23.040.3629--29.6720.2443.90---4.33--
Humanwell Healthcare Group Co Ltd24.18bn1.43bn31.34bn17.65k21.971.66--1.300.87410.874114.8411.590.65193.632.481,369,715.005.006.408.7312.5544.5343.837.679.901.40362.140.288925.973.713.13-37.7011.154.7556.54
Beijing Tiantan Biological Products Corp6.42bn1.32bn32.23bn5.30k24.492.81--5.020.66560.66563.255.800.40020.938211.211,212,453.0011.2511.9316.0616.7945.6550.6928.1029.693.08--0.015216.2416.4412.9439.5820.4515.1923.56
Sunshine Guojian Pharmcutcl Shngh Co Ltd1.37bn870.39m36.34bn995.0041.956.15--26.531.401.402.219.560.1861.544.551,377,045.0011.663.1415.353.3474.8877.3762.6516.951.97--0.0012.5717.700.2733139.1525.1716.61--
Gan & Lee Pharmaceuticals3.85bn925.74m38.82bn5.25k41.453.44--10.091.571.576.5418.880.31580.90719.73733,533.107.606.198.106.5874.6281.8024.0622.315.57--0.00144.1216.771.0280.75-12.041.63--
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd77.54bn2.99bn39.03bn28.14k13.671.08--0.50341.841.8447.6923.320.95485.794.332,755,662.003.835.337.3610.9516.2318.074.015.281.31--0.287328.87-0.6922.92-30.09-2.32-14.016.32
Beijing Tong Ren Tang Co Ltd18.09bn1.35bn41.97bn17.88k31.003.07--2.320.98710.987113.199.960.57360.937611.401,011,323.005.998.1311.7215.9543.1946.0210.4513.341.89--0.162933.284.126.97-8.549.142.305.64
Beijing Wantai Biolog Pha Ent Co Ltd1.80bn-333.84m50.78bn3.79k--4.20--28.28-0.2438-0.24381.389.560.12341.110.8599473,789.40-2.3017.63-2.6922.6348.3383.87-18.6733.203.82--0.02959.99-59.2513.66-91.49-12.6540.51--
Data as of Feb 13 2026. Currency figures normalised to Beijing Tong Ren Tang Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.26%Per cent of shares held by top holders
HolderShares% Held
Perseverance Asset Management LPas of 30 Sep 202415.00m1.09%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 202513.70m1.00%
E Fund Management Co., Ltd.as of 30 Sep 202410.71m0.78%
Harvest Fund Management Co., Ltd.as of 30 Jun 20258.19m0.60%
China Asset Management Co., Ltd.as of 30 Jun 20257.48m0.55%
China Universal Asset Management Co., Ltd.as of 30 Jun 20254.51m0.33%
GF Fund Management Co., Ltd.as of 30 Jun 20253.76m0.27%
The Vanguard Group, Inc.as of 04 Feb 20263.49m0.25%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20253.41m0.25%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20251.89m0.14%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.